A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of SGN-35 and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell Transplant
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Progression-free survival
Until disease progression or study closure
No
Naomi Hunder, MD
Study Director
Seattle Genetics, Inc.
United States: Food and Drug Administration
SGN35-005
NCT01100502
April 2010
April 2016
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |
Fred Hutchinson Cancer Research Center | Seattle, Washington 98109 |
University of Michigan Comprehensive Cancer Center | Ann Arbor, Michigan 48109-0752 |
Washington University School of Medicine | Saint Louis, Missouri 63110 |
University of Rochester Medical Center | Rochester, New York 14642 |
Hackensack University Medical Center | Hackensack, New Jersey 07601 |
City of Hope National Medical Center | Los Angeles, California 91010 |
Baylor University Medical Center | Dallas, Texas 75246 |
Western Pennsylvania Cancer Institute | Pittsburgh, Pennsylvania 15224 |
Stanford Cancer Center | Stanford, California 94305-5824 |
University of Minnesota | Minneapolis, Minnesota 55455 |
Northwestern University | Chicago, Illinois 60611 |
H. Lee Moffitt Cancer Center & Research Institute | Tampa, Florida 33612 |
Dana Farber Cancer Institute | Boston, Massachusetts 02115 |
Johns Hopkins Medical Center | Baltimore, Maryland |
Cancer Center of the Carolinas | Greenville, South Carolina 29615 |
University of California at San Francisco | San Francisco, California 94115 |
Northside Hospital | Atlanta, Georgia 30342 |
Saint Francis Hospital | Greenville, South Carolina 29601 |
New York University Cancer Institute | New York, New York 10016 |
Colorado Blood Cancer Institute | Denver, Colorado 80218 |
Karmanos Cancer Institute / Wayne State University | Detroit, Michigan 48201 |
MD Anderson Cancer Center / University of Texas | Houston, Texas 77030-4003 |
Cardinal Bernardin Cancer Center / Loyola University Medical Center | Maywood, Illinois 60153 |
UNC Lineberger Comprehensive Cancer Center / University of North Carolina | Chapel Hill, North Carolina 27599 |
University of Chicago Section of Hematology/Oncology Lymphoma Program | Chicago, Illinois 60637-1470 |
Indiana University School of Medicine Simon Cancer Center 535 Barnhill Drive, RT 380 | Indianapolis, Indiana 46202 |
Cleveland Clinic, The | Cleveland, Ohio 44195 |
James Cancer Hospital / Ohio State University | Columbus, Ohio 43210 |
Oregon Health and Science University / Center for Hematologic Malignancies | Portland, Oregon 97239-3098 |
Temple Bone Marrow Transplant Program | Philadelphia, Pennsylvania 19111 |
Virginia Commonwealth University Medical Center | Richmond, Virginia 23298 |